Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06279429
Status:
RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-01-24
Brief Title:
Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia
Sponsor:
Kuang Tien General Hospital
Organization:
Kuang Tien General Hospital
Study Overview
Official Title:
Sucrosomial Iron on Insomnia in Non-dialysis Chronic Kidney Disease Patients With Iron Deficiency Anemia
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Insomnia or sleep disturbance is a common disorder in patients with chronic kidney disease CKD but is often unrecognized and undertreated It is known that sleep disorders may indirectly cause a variety of diseases and affect quality of life The most common sleep disorders that occur in CKD are insomnia excessive daytime sleepiness obstructive or central sleep apnea SA and sleep disorders This study evaluates the effectiveness and safety of Sideral Sucrosomial Iron and iron chewable tablets 100mg commonly used in health insurance on sleep disorders in patients with CKD and iron deficiency anemia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None